Literature DB >> 19867846

AGGLUTINATION PHENOMENA IN LOBAR PNEUMONIA.

H T Chickering1.   

Abstract

1. Agglutinins are present in the blood of patients suffering from lobar pneumonia during some stage of the disease in a large percentage (73.8 per cent.) of the cases due to pneumococci belonging in groups I, II, and IV. 2. In most very severe and fatal cases agglutinins cannot be demonstrated, and it is probable that their absence during the later days of the disease may have unfavorable prognostic significance. 3. No agglutinins are demonstrable by the technique employed in the blood of patients suffering from infection with Pneumococcus mucosus (group III). 4. In certain cases agglutinins may be demonstrable for only one day, and in other cases they may persist for several weeks. 5. When agglutinins are demonstrable they usually appear at about the time of the crisis. 6. It has not been possible to demonstrate that treatment with immune serum has any effect on the appearance of agglutinins. 7. The agglutinins present in cases due to organisms of types I and II are always specific for the type of organism causing the infection. In certain cases the agglutination reaction may be more active or appear earlier when the homologous organism is employed than when other organisms of the group are used in the test. In cases due to organisms of type IV, the serum never causes agglutination of any organism except the homologous one.

Entities:  

Year:  1914        PMID: 19867846      PMCID: PMC2125236          DOI: 10.1084/jem.20.6.599

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS.

Authors:  F M Hanes
Journal:  J Exp Med       Date:  1914-01-01       Impact factor: 14.307

2.  THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA.

Authors:  A R Dochez
Journal:  J Exp Med       Date:  1912-11-01       Impact factor: 14.307

  2 in total
  3 in total

1.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

2.  IMMUNOLOGICAL STUDIES IN PNEUMONIA.

Authors:  R Weil; J C Torrey
Journal:  J Exp Med       Date:  1916-01-01       Impact factor: 14.307

3.  STUDIES ON THE PNEUMONIC EXUDATE : IV. THE PRESENCE IN THE PNEUMONIC LUNG OF A SOLUBLE SUBSTANCE INHIBITING AGGLUTINATION BY THE HOMOLOGOUS SERUM.

Authors:  F T Lord; R N Nye
Journal:  J Exp Med       Date:  1921-07-31       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.